Real-time enrollment status for this resectable intrahepatic cholangiocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:00 AM UTC
| NCT Number | NCT06050252 |
| Recruiting Status | Recruiting |
| Condition | Resectable Intrahepatic Cholangiocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 27 participants |
| Active Locations | 58 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 7, 2026 (6 days ago) |
As of July 13, 2026: Clinical trial NCT06050252 is currently recruiting participants. This clinical trial study for resectable intrahepatic cholangiocarcinoma is actively seeking new participants at 58 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06050252 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 58 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06050252 was last updated 6 days ago (July 7, 2026). HelloStudys verifies this status automatically.